Tvardi Therapeutics Statistics
Total Valuation
TVRD has a market cap or net worth of $14.07 million. The enterprise value is -$10.73 million.
Important Dates
The next estimated earnings date is Thursday, August 13, 2026, before market open.
| Earnings Date | Aug 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TVRD has 9.38 million shares outstanding. The number of shares has increased by 463.13% in one year.
| Current Share Class | 9.38M |
| Shares Outstanding | 9.38M |
| Shares Change (YoY) | +463.13% |
| Shares Change (QoQ) | +0.01% |
| Owned by Insiders (%) | 23.20% |
| Owned by Institutions (%) | 37.68% |
| Float | 5.67M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.97 |
| P/TBV Ratio | 0.99 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.25, with a Debt / Equity ratio of 0.01.
| Current Ratio | 2.25 |
| Quick Ratio | 2.22 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -68.64% |
| Return on Invested Capital (ROIC) | -103.40% |
| Return on Capital Employed (ROCE) | -202.25% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.29M |
| Employee Count | 12 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -94.47% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -94.47% |
| 50-Day Moving Average | 3.20 |
| 200-Day Moving Average | 7.75 |
| Relative Strength Index (RSI) | 16.55 |
| Average Volume (20 Days) | 96,236 |
Short Selling Information
The latest short interest is 436,072, so 4.65% of the outstanding shares have been sold short.
| Short Interest | 436,072 |
| Short Previous Month | 490,170 |
| Short % of Shares Out | 4.65% |
| Short % of Float | 7.69% |
| Short Ratio (days to cover) | 8.97 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -29.45M |
| Pretax Income | -15.44M |
| Net Income | -15.44M |
| EBITDA | -29.35M |
| EBIT | -29.45M |
| Earnings Per Share (EPS) | -$2.48 |
Full Income StatementBalance Sheet
The company has $24.98 million in cash and $174,000 in debt, giving a net cash position of $24.81 million or $2.64 per share.
| Cash & Cash Equivalents | 24.98M |
| Total Debt | 174,000 |
| Net Cash | 24.81M |
| Net Cash Per Share | $2.64 |
| Equity (Book Value) | 14.51M |
| Book Value Per Share | 1.55 |
| Working Capital | 14.07M |
Full Balance SheetCash Flow
| Operating Cash Flow | -21.67M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 95,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -21.67M |
| FCF Per Share | -$2.31 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |